Fig. 7From: Numerical simulation of vascular tumour growth under antiangiogenic treatment: addressing the paradigm of single-agent bevacizumab therapy with the use of experimental dataThe shortest path to a more aggressive tumour and towards a less aggressive tumour. a The effect of perturbing λ 1, c and d by 20 % in order to construct a more aggressive tumour. b The effect of perturbing λ 1, c and d by 20 % in order to construct a less aggressive tumour. c Selection of an earlier end-point (day 10): the effect of perturbing λ 1, c and d by 20 % in order to construct a more aggressive tumour. d Selection of an earlier end-point (day 15): the effect of perturbing λ 1, c and d by 20 % in order to construct a less aggressive tumourBack to article page